Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathies.

8e ), and marginally significant but variable effects on tubule wall area (Supplemental Fig. 8e ) at lower belumosudil doses, consistent with the variability in functional ROCK2 inhibition in vivo for these animals.

also in 26,082 other papers